Breast Cancer Clinical Trial
Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
Summary
Pre-clinical data suggests that combination therapy with gemcitabine and carboplatin is synergistic, and both drugs may be synergistic with trastuzumab. Additionally, recent clinical data suggest that the combination of gemcitabine with platinum is an active regimen in metastatic breast cancer. This study will test the combination of gemcitabine with carboplatin in patients with metastatic breast cancer. Patients with Her2/neu overexpression will be stratified to receive trastuzumab in addition to gemcitabine and carboplatin.
Full Description
Upon determination of eligibility, all patients will receive the following treatment:
Gemcitabine + Carboplatin
Eligibility Criteria
Inclusion Criteria:
To be included in this study, you must meet the following criteria:
Locally advanced or metastatic breast cancer
Measurable disease as per RECIST criteria
No prior chemotherapy in the metastatic breast setting
Prior chemotherapy and/or hormonal therapy for early stage breast cancer
Adjuvant Herceptin is allowed
Prior radiation therapy in either the metastatic or early stage setting
Patients may have received any number of hormonal therapies
Age >18 years
Only women are eligible for the study
Able to perform activities of daily living with minimal assistance
Normal organ and bone marrow function
Patients who will be receiving Trastuzumab must have normal heart function
Sign a written informed consent document
Exclusion Criteria:
You cannot participate in this study if any of the following apply to you:
Received prior chemotherapy for metastatic breast cancer
Known leptomeningeal carcinomatosis
Uncontrolled brain metastasis
Uncontrolled intercurrent illness
Pregnant or lactating
History of other non-breast cancer malignancy
Received prior chemotherapy for early stage breast cancer within 6 months
Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Nashville Tennessee, 37203, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.